Skip to content
Peptigraph home

Tirzepatide for Sleep: What the Evidence Shows

What human and animal studies show about Tirzepatide for sleep, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
None graded
no study with an outcome for sleep (PubMed search, 2 Oct 2026)
Human studies
None found
with an outcome for sleep, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for sleep, in our evidence file (PubMed search, 2 Oct 2026)

Evidence for sleep

None of the study abstracts we summarised for Tirzepatide reported an outcome for sleep (PubMed search, 2 Oct 2026). Claims that it helps with sleep are unproven.

How strong is it?

Strongest evidence:No graded study for sleep (PubMed search, 2 Oct 2026)

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Insomnia versus sleep apnea

MedlinePlus defines insomnia as a common sleep disorder in which you may have trouble falling asleep, staying asleep, or both.[16]

No insomnia trial is cited here. The closest sleep trial is in obstructive sleep apnea, where patient-reported sleep impairment and disturbance were key secondary end points.[17]

The authors of that trial concluded tirzepatide improved sleep-related patient-reported outcomes in people with moderate-to-severe sleep apnea and obesity.[17]

Insomnia as a reported symptom

A social media study of posts about GLP-1 drugs found insomnia, anxiety and depression mentioned together often (50-100 co-occurrence mentions). That is conversation data, not a measured effect of tirzepatide.[18]

The Mounjaro patient information lists drowsiness among its signs of low blood sugar.[19]

Other peptides people research for sleep

All peptides for sleep, compared

Common questions

Does Tirzepatide help with sleep?

None of the studies we summarised for Tirzepatide (PubMed search, 2 Oct 2026) measured an outcome for sleep. Treat claims that it helps with sleep as unproven.

Is Tirzepatide approved for sleep?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

What is the best peptide for sleep?

There is no single answer. Our sleep overview compares each candidate by evidence grade and legal status rather than by popularity.

Does tirzepatide cause insomnia?

This page has no label or trial evidence that tirzepatide causes insomnia. The only link cited is a social media study that grouped insomnia with anxiety and depression.[18]

Does tirzepatide improve sleep quality?

The SURMOUNT-OSA trials found improved sleep-related patient-reported outcomes in people with obesity and obstructive sleep apnea. No trial in other groups is cited here.[17]

More on Tirzepatide

Sources

  1. 1PubMed search: tirzepatide[ti] AND (SURMOUNT[tiab] OR SURPASS[tiab]) AND randomized controlled trial[pt] (93 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  2. 2PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-4 OR SURPASS-5 OR "versus semaglutide" OR "SURPASS-CVOT" OR dulaglutide) (143 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  3. 3PubMed search: tirzepatide[ti] AND (steatohepatitis OR NASH OR "heart failure" OR HFpEF OR "preserved ejection" OR cardiovascular) (410 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  4. 4PubMed search: tirzepatide[ti] AND (SURPASS-2 OR SURPASS-3 OR SURPASS-1 OR SURPASS-5 OR "SURPASS J-mono") AND randomized controlled trial[pt] (24 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: tirzepatide[ti] AND (steatohepatitis OR "heart failure" OR "SUMMIT" OR "SYNERGY-NASH" OR "phase 2") AND randomized controlled trial[pt] (21 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: tirzepatide[tiab] AND (meta-analysis[pt] OR systematic review[pt]) AND (weight OR glycemic OR HbA1c OR obesity) (178 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: tirzepatide[tiab] AND (pharmacokinetic*[tiab] OR half-life[tiab]) AND humans[mh] (49 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: tirzepatide[ti] AND (insulin degludec OR "SURPASS-3") AND "type 2 diabetes"[ti] AND randomized controlled trial[pt] (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: tirzepatide[ti] AND (cardiovascular outcomes OR "SURPASS-CVOT" OR "major adverse") (228 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: tirzepatide[tiab] AND (depression OR anxiety OR ADHD OR osteoporosis OR "bone mineral" OR menopause OR "rheumatoid" OR arthritis OR testosterone) (121 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: tirzepatide[tiab] AND ("body composition"[tiab] OR "lean mass"[tiab] OR "visceral fat"[tiab] OR "fat mass"[tiab]) AND humans[mh] (91 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: tirzepatide[tiab] AND (blood pressure[tiab] OR cholesterol[tiab] OR lipid*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (58 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: tirzepatide[tiab] AND (SURPASS-CVOT OR "cardiovascular events" ) AND "dulaglutide"[tiab] AND randomized controlled trial[pt] (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: tirzepatide[tiab] AND (depression[tiab] OR anxiety[tiab] OR "mental health"[tiab] OR ADHD[tiab] OR "binge eating"[tiab]) AND (randomized controlled trial[pt] OR clinical trial[pt]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15PubMed search: tirzepatide[tiab] AND (menopaus*[tiab] OR PCOS[tiab] OR "polycystic"[tiab] OR testosterone[tiab] OR hypogonadism[tiab]) (55 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  16. 16medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
  17. 17Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.The New England journal of medicine · 2024PMID 38912654Accessed 2 Oct 2026
  18. 18Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024.JMIR infodemiology · 2025PMID 40706081Accessed 2 Oct 2026
  19. 19MOUNJARO prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.